Eczematous reaction to IVIG for the treatment of dermatomyositis
Juliana Berk-Krauss +3 more
openalex +1 more source
Effects of conventional immunosuppressive treatment on CD244+ (CD28null) and FOXP3+ T cells in the inflamed muscle of patients with polymyositis and dermatomyositis [PDF]
Jayesh M. Pandya +7 more
openalex +1 more source
Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: A Randomized Clinical Trial [PDF]
Victoria P. Werth +14 more
openalex +1 more source
Acute acalculous cholecystitis in a patient with juvenile dermatomyositis [PDF]
Bruno Sanches +3 more
openalex +1 more source
Combination Therapy with Rituximab, Tofacitinib and Pirfenidone in a Patient with Rapid Progressive Interstitial Lung Disease (RP-ILD) Due to MDA5 Antibody-Associated Dermatomyositis: A Case Report [PDF]
Tsai‐Hung Yen +3 more
openalex +1 more source
Cutaneous manifestations of dermatomyositis in individuals with dark skin: A review of reported cases [PDF]
Edgar Akuffo‐Addo +4 more
openalex +1 more source
AB0675 Anti-mda5 positive dermatomyositis: an emerging entity [PDF]
Vera Ortiz-Santamaría +4 more
openalex +1 more source
Anti-nuclear matrix protein 2 antibody-positive idiopathic inflammatory myopathies represent extensive myositis without dermatomyositis-specific rash [PDF]
Yuki Ichimura +20 more
openalex +1 more source
Intramural ureteric calcification in dermatomyositis mimicking pelviureteric junction obstruction
Juvenile dermatomyositis classically manifests as necrotising vasculitis in multiple organs. It mainly involves the vessels of skin and muscle and is associated with subcutaneous deposits of calcium.
Shah Amar, Thakur Rakesh, Parashar Karan
doaj
POS0607 BREPOCITINIB PREVENTS TYPE-I INTERFERON INDUCED DAMAGE IN CULTURED MYOCYTES AND ENDOTHELIAL CELLS INDICATING A POTENTIAL ROLE IN THE TREATMENT OF DERMATOMYOSITIS [PDF]
Jiří Vencovský +3 more
openalex +1 more source

